TCS Launches AI Agent Platform To Accelerate Drug Discovery
· Technology · Business Standard
Tata Consultancy Services has introduced a new AI-powered agent platform designed to streamline the drug development process for pharmaceutical companies. The platform utilizes autonomous agents to manage complex research tasks, aiming to reduce the time and cost associated with bringing new medicines to market. By automating data analysis and clinical trial workflows, the technology seeks to improve efficiency in the highly regulated life sciences sector. The company plans to integrate these AI agents across its existing digital service offerings to support global drug discovery initiatives.
Why it matters
This platform could significantly shorten the drug development lifecycle for pharmaceutical firms, potentially lowering costs for life-saving treatments and accelerating medical innovation.
Read the original report — Business Standard
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.